[1] |
Cogliati Dezza F, Oliva A, Cancelli F, et al. Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection. Diagn Microbiol Infect Dis 2021; 100: 115347.
DOI
URL
|
[2] |
Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020; 133: 1039-43.
|
[3] |
Kannan S, Shaik Syed Ali P, Sheeza A. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci 2021; 25: 8019-22.
|
[4] |
Li Wan Po A. Omicron variant as nature's solution to the COVID-19 pandemic. J Clin Pharm Ther 2022; 47: 3-5.
DOI
PMID
|
[5] |
Lauring AS, Tenforde MW, Chappell JD, et al. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ 2022; 376: e069761.
|
[6] |
Bennasrallah C, Zemni I, Dhouib W, et al. Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19. Int J Infect Dis 2021; 105: 463-9.
DOI
PMID
|
[7] |
Hu X, Xing Y, Jia J, et al. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. The Science of the total environment 2020; 728: 138812.
DOI
URL
|
[8] |
Del Rio C, Omer SB, Malani PN. Winter of Omicron-the evolving COVID-19 pandemic. JAMA 2022; 327: 319-20.
DOI
URL
|
[9] |
Gajewski A, Kośmider A, Nowacka A, Puk O, Wiciński M. Potential of herbal products in prevention and treatment of COVID-19. Biomed Pharmacother 2021; 143: 112150.
|
[10] |
Wei X, Xing A, Chunguang X, et al. Observation of the tongue manifestation of 36 cases of COVID-19. Shanxi Zhong Yi Yao Da Xue Xue Bao 2020; 43: 16-20.
|
[11] |
Si MY, Yan FC, Zhong XW, et al. Analysis of the relationship between clinical features and tongue manifestations of 40 cases with corona virus disease 2019. Beijing Zhong Yi Yao 2020; 39: 111-4.
|
[12] |
Zhou GB, Huang DH, Cai Y, Huang KF, Xie DP. The relationship between the characteristics of tongue manifestation and clinical classification in patients with coronavirus disease 2019. Zhong Yi Za Zhi 2020; 61: 1657-60.
|
[13] |
National Health Commission of the People’s Republic of China. Diagnosis and treatment plan for COVID-19 (trial version 9). Guo Ji Liu Xing Bing Xue Chuan Ran Bing Za Zhi 2022; 49: 73-80.
|
[14] |
Zhang SQ, Li XF, Pei LM, et al. Clinical and therapeutic characteristics of 983 light and common patients with COVID-19 in Wuhan square-cabin hospitals. Liaoning Zhong Yi Za Zhi 2021; 48: 170-4.
|
[15] |
Lu YF, Yang ZG, Wang M, et al. Analysis on Chinese medical clinical characteristics of 50 patients with novel coronavirus-infected pneumonia. Shanghai Zhong Yi Yao Da Xue Xue Bao 2020; 34: 17-21.
|
[16] |
Brandal LT, MacDonald E, Veneti L, et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro surveill 2021; 26: 2101147.
|
[17] |
Zhang X, Zhang W, Chen S. Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet 2022; 399: 2011-12.
DOI
URL
|
[18] |
Chen J, Wang R, Gilby NB, Wei GW. Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model 2022; 62: 412-22.
DOI
URL
|
[19] |
Li WF, Hu CC, Ding YL, Yuan B. Overview of meta-analysis of Lianhua Qingwen in treatment of virus-infection. Zhong Guo Zhong Yao Za Zhi 2022; 47: 4505-16.
|
[20] |
Chu L, Huang F, Zhang M, Huang B, Wang Y. Current status of Traditional Chinese Medicine for the treatment of COVID-19 in China. Chin Med 2021; 16: 63.
DOI
URL
|
[21] |
Chen Y, Zhang JJ, Liu Y, Shang HC. Comprehensive comparison and analysis of the prevention and treatment of coronavirus disease 2019 and severe acute respiratory syndrome with Traditional Chinese Medicine. World J Tradit Chin Med 2020; 6: 124-31.
DOI
URL
|
[22] |
Liang SB, Fang M, Liang CH, et al. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: a rapid systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 2021; 60: 102744.
DOI
URL
|
[23] |
Zhang XX, et al. Antiviral properties of Traditional Chinese Medicine against coronavirus: Research clues for coronavirus disease-2019. World J Tradit Chin Med 2020; 6:132-8.
DOI
URL
|
[24] |
Wang YF, Du M, Su R. Analysis of interventional clinical research protocols related to coronavirus disease 2019 and future expectations. World J Tradit Chin Med 2020; 6:139-44.
DOI
URL
|
[25] |
Li BH, Li ZY, Liu MM, Tian JZ, Cui QH. Progress in Traditional Chinese Medicine against respiratory viruses: a review. Front Pharmacol 2021; 12: 743623.
DOI
URL
|
[26] |
Jin YH, Zhan QY, Peng ZY, et al. Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version). Mil Med Res 2020; 7: 41.
|
[27] |
Hu K, Guan WJ, Bi Y, et al. Efficacy and safety of Lianhua-qingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine 2021; 85: 153242.
DOI
URL
|
[28] |
Zhou S, Feng J, Xie Q, et al. Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: a randomized controlled multicenter trial. Phytomedicine 2021; 89: 153612.
DOI
URL
|
[29] |
Shen X, Yin F. The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule. Biomed Pharmacother 2021; 142: 111998.
DOI
PMID
|
[30] |
Meo SA, Meo AS, Al-Jassir FF, Klonoff DC. Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics. Eur Rev Med Pharmacol Sci 2021; 25: 8012-18.
|
[31] |
Lee TC, Lo LC, Wu FC. Traditional Chinese Medicine for metabolic syndrome via TCM pattern differentiation: tongue diagnosis for predictor. Evid Based Complement Alternat Med 2016; 2016: 1971295.
|
[32] |
Anastasi JK, Currie LM, Kim GH. Understanding diagnostic reasoning in TCM practice: Tongue diagnosis. Altern Ther Health Med 2009; 15: 18-28.
|
[33] |
Zhang S, Yang Z, Chen ZL, et al. Efficacy and safety of "three Chinese patent medicines and three TCM prescriptions" for COVID-19: a systematic review and network Meta-analysis. Evid Based Complement Alternat Med; 2022: 4654793.
|